China Dermatomycoses Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Dermatomycoses Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sol-Gel Technologies Ltd

    • Anacor Pharmaceuticals Inc

    • Helix BioMedix Inc

    • Vyome Biosciences Pvt Ltd

    • Daewoong Pharmaceutical Co Ltd

    • Viamet Pharmaceuticals Inc

    • Blueberry Therapeutics Ltd

    • Biolab Farmaceutica Ltda

    • Dermala Inc

    By Type:

    • Others

    • Clotrimazole

    • BB-2603

    • Dapaconazole

    By Application:

    • Hospital

    • Others

    • Clinic

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Dermatomycoses Drug Market Overview 2018-2029

    • 1.1 China Dermatomycoses Drug Industry Development Overview

    • 1.2 China Dermatomycoses Drug Industry Development History

    • 1.3 China Dermatomycoses Drug Industry Market Size (2018-2029)

    • 1.4 China Dermatomycoses Drug Market Analysis by Type from Production Side

      • 1.4.1 China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Clotrimazole (2018-2029)

      • 1.4.3 China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of BB-2603 (2018-2029)

      • 1.4.4 China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Dapaconazole (2018-2029)

    • 1.5 China Dermatomycoses Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.2 China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • 1.6 China Dermatomycoses Drug Market Analysis by Region

      • 1.6.1 North China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Dermatomycoses Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Dermatomycoses Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Dermatomycoses Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Dermatomycoses Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Dermatomycoses Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Dermatomycoses Drug Industry Development

    Chapter 3 Dermatomycoses DrugIndustry Chain Analysis

    • 3.1 Dermatomycoses Drug Industry Chain

    • 3.2 Dermatomycoses Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Dermatomycoses Drug Market

    • 3.3 Dermatomycoses Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Dermatomycoses Drug Market

    Chapter 4 China Dermatomycoses Drug Market, by Type

    • 4.1 China Dermatomycoses Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Dermatomycoses Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Dermatomycoses Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Dermatomycoses Drug Production Volume and Growth Rate of Others

      • 4.5.2 China Dermatomycoses Drug Production Volume and Growth Rate of Clotrimazole

      • 4.5.3 China Dermatomycoses Drug Production Volume and Growth Rate of BB-2603

      • 4.5.4 China Dermatomycoses Drug Production Volume and Growth Rate of Dapaconazole

    Chapter 5 China Dermatomycoses Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Dermatomycoses Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Dermatomycoses Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Dermatomycoses Drug Market Size and Growth Rate of Hospital

      • 5.5.2 China Dermatomycoses Drug Market Size and Growth Rate of Others

      • 5.5.3 China Dermatomycoses Drug Market Size and Growth Rate of Clinic

    Chapter 6 China Dermatomycoses Drug Market, by Region

    • 6.1 China Dermatomycoses Drug Production Volume and Production Value, by Region

    • 6.2 China Dermatomycoses Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Dermatomycoses Drug Market Analysis

    • 7.1 North China Dermatomycoses Drug Market, by Type

    • 7.2 North China Dermatomycoses Drug Market, by Application

    Chapter 8 Central China Dermatomycoses Drug Market Analysis

    • 8.1 Central China Dermatomycoses Drug Market, by Type

    • 8.2 Central China Dermatomycoses Drug Market, by Application

    Chapter 9 South China Dermatomycoses Drug Market Analysis

    • 9.1 South China Dermatomycoses Drug Market, by Type

    • 9.2 South China Dermatomycoses Drug Market, by Application

    Chapter 10 East China Dermatomycoses Drug Market Analysis

    • 10.1 East China Dermatomycoses Drug Market, by Type

    • 10.2 East China Dermatomycoses Drug Market, by Application

    Chapter 11 Northeast China Dermatomycoses Drug Market Analysis

    • 11.1 Northeast China Dermatomycoses Drug Market, by Type

    • 11.2 Northeast China Dermatomycoses Drug Market, by Application

    Chapter 12 Southwest China Dermatomycoses Drug Market Analysis

    • 12.1 Southwest China Dermatomycoses Drug Market, by Type

    • 12.2 Southwest China Dermatomycoses Drug Market, by Application

    Chapter 13 Northwest China Dermatomycoses Drug Market Analysis

    • 13.1 Northwest China Dermatomycoses Drug Market, by Type

    • 13.2 Northwest China Dermatomycoses Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sol-Gel Technologies Ltd

        • 14.1.1 Sol-Gel Technologies Ltd Company Profile

        • 14.1.2 Sol-Gel Technologies Ltd Dermatomycoses Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Anacor Pharmaceuticals Inc

        • 14.2.1 Anacor Pharmaceuticals Inc Company Profile

        • 14.2.2 Anacor Pharmaceuticals Inc Dermatomycoses Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Helix BioMedix Inc

        • 14.3.1 Helix BioMedix Inc Company Profile

        • 14.3.2 Helix BioMedix Inc Dermatomycoses Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Vyome Biosciences Pvt Ltd

        • 14.4.1 Vyome Biosciences Pvt Ltd Company Profile

        • 14.4.2 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Daewoong Pharmaceutical Co Ltd

        • 14.5.1 Daewoong Pharmaceutical Co Ltd Company Profile

        • 14.5.2 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Viamet Pharmaceuticals Inc

        • 14.6.1 Viamet Pharmaceuticals Inc Company Profile

        • 14.6.2 Viamet Pharmaceuticals Inc Dermatomycoses Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Blueberry Therapeutics Ltd

        • 14.7.1 Blueberry Therapeutics Ltd Company Profile

        • 14.7.2 Blueberry Therapeutics Ltd Dermatomycoses Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Biolab Farmaceutica Ltda

        • 14.8.1 Biolab Farmaceutica Ltda Company Profile

        • 14.8.2 Biolab Farmaceutica Ltda Dermatomycoses Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Dermala Inc

        • 14.9.1 Dermala Inc Company Profile

        • 14.9.2 Dermala Inc Dermatomycoses Drug Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Dermatomycoses Drug Industry Research Conclusions

    • 15.2 Dermatomycoses Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Dermatomycoses Drug Industry Market Size (2018-2029)

    • Figure China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Clotrimazole (2018-2029)

    • Figure China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of BB-2603 (2018-2029)

    • Figure China Dermatomycoses Drug Production Volume, Production Value and Growth Rate of Dapaconazole (2018-2029)

    • Figure China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Dermatomycoses Drug Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure North China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Dermatomycoses Drug Market Size and Growth Rate from 2018-2029

    • Figure Dermatomycoses Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Dermatomycoses Drug Market Share by Type in 2018

    • Figure China Dermatomycoses Drug Market Share by Type in 2023

    • Figure China Dermatomycoses Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Dermatomycoses Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Dermatomycoses Drug Production Volume and Growth Rate of Clotrimazole (2018-2023)

    • Figure China Dermatomycoses Drug Production Volume and Growth Rate of BB-2603 (2018-2023)

    • Figure China Dermatomycoses Drug Production Volume and Growth Rate of Dapaconazole (2018-2023)

    • Figure China Dermatomycoses Drug Market Share by Application in 2018

    • Figure China Dermatomycoses Drug Market Share by Application in 2023

    • Figure China Dermatomycoses Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Dermatomycoses Drug Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Dermatomycoses Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Dermatomycoses Drug Market Size and Growth Rate of Clinic (2018-2023)

    • Table China Dermatomycoses Drug Production Volume by Region (2018-2023)

    • Table China Dermatomycoses Drug Production Volume Share by Region (2018-2023)

    • Figure China Dermatomycoses Drug Production Volume Share by Region (2018-2023)

    • Table China Dermatomycoses Drug Production Value by Region (2018-2023)

    • Table China Dermatomycoses Drug Production Value Share by Region (2018-2023)

    • Figure China Dermatomycoses Drug Production Value Share by Region (2018-2023)

    • Table China Dermatomycoses Drug Sales Volume by Region (2018-2023)

    • Table China Dermatomycoses Drug Sales Volume Share by Region (2018-2023)

    • Figure China Dermatomycoses Drug Sales Volume Share by Region (2018-2023)

    • Table China Dermatomycoses Drug Sales Value by Region (2018-2023)

    • Table China Dermatomycoses Drug Sales Value Share by Region (2018-2023)

    • Figure China Dermatomycoses Drug Sales Value Share by Region (2018-2023)

    • Table North China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table North China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure North China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table North China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table North China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table Central China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table Central China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table Central China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table South China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table South China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure South China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table South China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table South China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table East China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table East China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure East China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table East China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table East China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table Northeast China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table Southwest China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Dermatomycoses Drug Production Volume by Type (2018-2023)

    • Table Northwest China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Dermatomycoses Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Dermatomycoses Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Dermatomycoses Drug Sales Volume Share by Application (2018-2023)

    • Table Sol-Gel Technologies Ltd Company Profile

    • Table Sol-Gel Technologies Ltd Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Anacor Pharmaceuticals Inc Company Profile

    • Table Anacor Pharmaceuticals Inc Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Helix BioMedix Inc Company Profile

    • Table Helix BioMedix Inc Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Vyome Biosciences Pvt Ltd Company Profile

    • Table Vyome Biosciences Pvt Ltd Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Daewoong Pharmaceutical Co Ltd Company Profile

    • Table Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Viamet Pharmaceuticals Inc Company Profile

    • Table Viamet Pharmaceuticals Inc Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Blueberry Therapeutics Ltd Company Profile

    • Table Blueberry Therapeutics Ltd Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Biolab Farmaceutica Ltda Company Profile

    • Table Biolab Farmaceutica Ltda Dermatomycoses Drug Revenue, Price and Gross (2018-2023)

    • Table Dermala Inc Company Profile

    • Table Dermala Inc Dermatomycoses Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.